Closing SGMO (Sangamo) underperform
That was a nice little score in less than a month. I don't even know what's driving the stock down so sharply, although I also don't know why it was so high to begin with. Anyway, I don't think Sangamo is headed for the Nastech wastebasket quite yet. I'm hoping for one more upward run before SB-509 flops and drives the company permanently into the toilet. It's still overpriced, and I won't get caught green thumbing another overpriced biotech. Learned that lesson at the beginning. But I'll red thumb it again over 12.